Early (2 weeks) vs. late (8 weeks) initiation of highly active antiretroviral treatment (HAART) significantly enhance survival of severely immunosuppressed HIV-infected adults with newly diagnosed tuberculosis: results of the CAMELIA clinical trial

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Blanc, François-Xavier, Sok, Thim, Laureillard, Didier, Borand, Laurence, Rekacewicz, Claire, Nerrienet, Eric, Madec, Yoann, Marcy, Olivier, Chan, Sarin, Prak, Narom, Kim, Chindamony, Kim Lak, Khemarin, Hak, Chanroeurn, Dim, Bunnet, Im Sin, Chhun, Sun, Sath, Guillard, Bertrand, Sar, Borann, Vong, Sirenda, Fernandez, Marcelo, Fox, Lawrence, Delfraissy, Jean-François, Goldfeld, Anne E
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BioMed Central 2011
Onderwerpen:
Oral Presentation
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3019404/
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items